Financial Summary (All financials)
In millions, except per share items | Mar-31-23 | Apr-01-22 | Apr-02-21 | Apr-03-20 | Mar-29-19 | Mar-30-18 | Mar-31-17 | Apr-01-16 |
Revenues | 3,338.0 | 2,796.0 | 2,551.0 | 2,490.0 | 2,456.0 | 2,559.0 | 4,019.0 | 3,600.0 |
Revenue growth | 19.4% | 9.6% | 2.4% | 1.4% | -4.0% | -36.3% | 11.6% | -9.0% |
Cost of goods sold | 589.0 | 408.0 | 362.0 | 393.0 | 455.0 | 463.0 | 853.0 | 615.0 |
Gross profit | 2,749.0 | 2,388.0 | 2,189.0 | 2,097.0 | 2,001.0 | 2,096.0 | 3,166.0 | 2,985.0 |
Gross margin | 82.4% | 85.4% | 85.8% | 84.2% | 81.5% | 81.9% | 78.8% | 82.9% |
Sales and marketing | 682.0 | 622.0 | 576.0 | 701.0 | 712.0 | 841.0 | 1,459.0 | 1,292.0 |
Research and development | 313.0 | 253.0 | 267.0 | 328.0 | 420.0 | 455.0 | 823.0 | 748.0 |
General and administrative | 286.0 | 392.0 | 215.0 | 368.0 | 410.0 | 487.0 | 564.0 | 295.0 |
EBITA | 1,468.0 | 1,121.0 | 1,131.0 | 700.0 | 459.0 | -67.0 | 47.0 | 514.0 |
EBITA margin | 44.0% | 40.1% | 44.3% | 28.1% | 18.7% | -2.6% | 1.2% | 14.3% |
Amortization of intangibles | 172.0 | 85.0 | 74.0 | 79.0 | 80.0 | 87.0 | 147.0 | 57.0 |
EBIT | 1,296.0 | 1,036.0 | 1,057.0 | 621.0 | 379.0 | -154.0 | -100.0 | 457.0 |
EBIT margin | 38.8% | 37.1% | 41.4% | 24.9% | 15.4% | -6.0% | -2.5% | 12.7% |
Pre-tax income | 804.0 | 1,042.0 | 872.0 | 819.0 | -107.0 | 244.0 | -262.0 | 392.0 |
Income taxes | 0.0 | 206.0 | 176.0 | 241.0 | 3.0 | -720.0 | -26.0 | 1,213.0 |
Tax rate | 0.0% | 19.8% | 20.2% | 29.4% | | | 9.9% | 309.4% |
Earnings from continuing ops | | 836.0 | 696.0 | 578.0 | -110.0 | 964.0 | -236.0 | -821.0 |
Earnings from discontinued ops | | | 0.0 | 0.0 | 0.0 | 0.0 | | |
Net income | 0.0 | 836.0 | 554.0 | 3,887.0 | 31.0 | 1,138.0 | -106.0 | 2,488.0 |
Net margin | 0.0% | 29.9% | 21.7% | 156.1% | 1.3% | 44.5% | -2.6% | 69.1% |
|
Diluted EPS | $0.00 | $1.41 | $1.16 | $0.90 | ($0.17) | $1.44 | ($0.38) | ($1.23) |
Shares outstanding (diluted) | 624.0 | 591.0 | 600.0 | 643.0 | 632.0 | 668.0 | 618.0 | 670.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|